Effects of commonly used immunosuppressants on graft-derived fibroblasts

Clinical and Experimental Immunology

Volumn 136, Issue 3, 2004, Pages 405-412

  Johnsson, C ^a   Gerdin, B ^a   Tufveson, G ^a  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Fibroblasts; Hyaluronan; Immunosuppression; Proliferation

Indexed keywords

CYCLOSPORIN; CYCLOSPORIN A; HERMES ANTIGEN; HYALURONIC ACID; IMMUNOSUPPRESSIVE AGENT; MYCOPHENOLIC ACID; PREDNISOLONE; RAPAMYCIN; TACROLIMUS;

ALLOGRAFT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL CULTURE; CELL ISOLATION; CELL PROLIFERATION; CELL SURFACE; CONTROLLED STUDY; DRUG EFFECT; FIBROBLAST; GRAFT REJECTION; HEART TRANSPLANTATION; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT;

ANIMALS; ANTIGENS, CD44; CELL DIVISION; CELLS, CULTURED; CYCLOSPORINE; DEPRESSION, CHEMICAL; FIBROBLASTS; GRAFT REJECTION; HEART TRANSPLANTATION; HYALURONIC ACID; IMMUNOSUPPRESSIVE AGENTS; MALE; MYCOPHENOLIC ACID; PREDNISOLONE; RATS; RATS, INBRED LEW; RATS, INBRED STRAINS; TACROLIMUS; TRANSPLANTATION, HOMOLOGOUS;

EID: 2542606797     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2249.2004.02488.x     Document Type: Article

References (31)

1. Hällgren R, Gerdin B, Tengblad A, Tufveson G. Accumulation of hyaluronan (hyaluronic acid) in myocardial interstitial tissue parallels development of transplantation edema in heart allografts in rats. J Clin Invest 1990; 85:668-73.
2. Hellkvist J, Tufveson G, Gerdin B, Johnsson C. Characterization of fibroblasts from rejecting tissue: the hyaluronan production is increased. Transplantation 2002; 74:1672-7.
3. Comper WD, Laurent TC. Physiological function of connective tissue polysaccharides. Physiol Rev 1978; 8:255-315.
4. Johnsson C, Hällgren R, Elvin A, Gerdin B, Tufveson G. Hyaluronidase ameliorates rejection-induced edema. Transplant Int 1999; 12:235-43.
5. McKee CM, Penno MB, Cowman M et al. Hyaluronan (HA) fragments induce chemokine gene expression in alveolar macrophages. J Clin Invest 1996; 98:2403-13.
6. Oertli B, Beck-Schimmer B, Fan X, Wüthrich RP. Mechanisms of hyaluronan-induced up-regulation of ICAM-1 and VCAM-1 expression by murine kidney tubular epithelial cells: hyaluronan triggers cell adhesion molecule expression through a mechanism involving activation of nuclear factor-κB and activating protein-1. J Immunol 1998; 161:3431-7.
7. Schenck P, Schneider S, Miehlke R, Prehm P. Synthesis and degradation of hyaluronate by synovia from patients with rheumatoid arthritis. J Rheumatol 1995; 22:400-5.
8. Sharpe RJ, Arndt KA, Bauer SI, Maione TE. Cyclosporin inhibits basic fibroblast growth factor-driven proliferation of human endothelial cells and keratinocytes. Arch Dermatol 1989; 125:1359-62.
9. Furue M, Gaspari AA, Katz SI. The effect of cyclosporin A on epidermal cells. II. Cyclosporin A inhibits proliferation of normal and transformed keratinocytes. J Invest Dermatol 1988; 90:796-300.
10. Gregory CR, Pratt RE, Huie P et al. Effects of treatment with cyclosporine, FK 506, rapamycin, mycophenolic acid, or deoxyspergualin on vascular muscle proliferation in vitro and in vivo. Transplant Proc 1993; 25:770-1.
11. Mohacsi PJ, Tüller D, Hulliger B, Wijngaard PLJ. Different inhibitory effects of immunosuppressive drugs on human and rat aortic smooth muscle and endothelial cell proliferation stimulated by platelet-derived growth factor or endothelial cell growth factor. J Heart Lung Transplant 1997; 16:484-92.
12. Johnsson C, Tufveson G, Hällgren R. Monitoring of intragraft pressure of rejecting organs. Increased tissue pressure can be reduced by hyaluronidase therapy. Transplantation 2000; 70:1575-80.
13. Knoflach A, Azuma H, Magee C et al. Immunomodulatory functions of low-molecular weight hyaluronate in an acute rat renal allograft rejection model. J Am Soc Nephrol 1999; 10:1059-66.
14. Coito AJ, Kupiec-Weglinski JW. Extracellular matrix proteins in organ transplantation. Transplantation 2000; 69:2465-73.
15. Riederer I, Silva-Barbosa SD, Rodrigues ML, Savino W. Local antilaminin antibody treatment alters the rejection pattern of murine cardiac allografts: correlation between cellular infiltration and extracellular matrix. Transplantation 2002; 74:1515-22.
16. Zander DS, Baz MA, Massey JK. Patterns and significance of CD44 expression in lung allografts. J Heart Lung Transplant 1999; 18:646-53.
17. Saarni H, Tammi M, Vuorio E. Effects of cortisol on glycosaminoglycans synthesized by normal and rheumatoid synovial fibroblasts in vitro. Scand J Rheumatol 1977; 6:222-4.
18. Smith TJ. Dexamethasone regulation of glycosaminoglycan synthesis in cultured human skin fibroblasts. J Clin Invest 1984; 74:2157-63.
19. Culty M, Nguyen HA, Underbill CB. The hyaluronan receptor (CD44) participates in the uptake and degradation of hyaluronan. J Cell Biol 1992; 116:1055-60.
20. Zhang W, Watson CE, Liu C, Williams KJ, Werth VP. Glucocorticoids induce a near-total suppression of hyaluronan synthase mRNA in dermal fibroblasts and in osteoblasts: a molecular mechanism contributing to organ atrophy. Biochem J 2000; 349:91-7.
21. Steinmann B, Bruckner P, Superti-Furga A. Cyclosporin A slows collagen triple-helix formation in vivo: indirect evidence for a physiologic role of peptidyl-prolyl cis-trans isomerase. J Biol Chem 1991; 266:1299-303.
22. Bartold PM. Regulation of human gingival fibroblast growth and synthetic activity by cyclosporine-A in vitro. J Periodontal Res 1989; 24:314-21.
23. Willershausen-Zonnchen B, Lemmen C, Schumacher U. Influence of cyclosporin A on growth and extracellular matrix synthesis of human fibroblasts. J Cell Physiol 1992; 152:397-402.
24. Newell J, Irwin CR. Comparative effects of cyclosporin on glycosaminoglycan synthesis by gingival fibroblasts. J Periodontol 1997; 68:443-7.
25. Yamada H, Nishimura F, Naruishi K et al. Phenytoin and cyclosporin A suppress the expression of MMP-1, TIMP-1, and cathepsin L, but not cathepsin B in cultured gingival fibroblasts. J Periodontol 2000; 71:955-60.
26. Smak-Gregoor PJ, van Gelder T, van Besouw NM. Mycophenolic acid trough levels after kidney transplantation in a cyclosporin-free protocol. Transplant Int 2000; 13:5333-5.
27. Räisänen-Sokolowski A, Vuoristo P, Myllarniemi M, Yilmaz S, Kallio E, Häyry P. Mycophenolate mofetil (MMF, RS-61443) inhibits inflammation and smooth muscle cell proliferation in rat aortic allografts. Transplant Immunol 1995; 3:342-51.
28. Meier-Kriesche H-U, Ojo AO, Arndorfer JA et al. Mycophenolate mofetil decreases the risk for chronic renal allograft failure. Transplant Proc 2001; 33:1005-6.
29. Akselband Y, Harding MW, Nelson PA. Rapamycin inhibits spontenous and fibroblast growth factor β-stimulated proliferation of endothelial cells and fibroblasts. Transplant Proc 1991; 23:2833-6.
30. Migita K, Eguchi K, Aoyagi T et al. The effects of the immunosuppressant rapamycin on the growth of rheumatoid arthritis (RA) synovial fibroblast. Clin Exp Immunol 1996; 104:86-91.
31. Salas-Prato M, Assalian A, Mehdi AZ, Duperre J, Thompson P, Brazeau P. Inhibition by rapamycin of PDGF- and bFGF-induced human tenon fibroblast proliferation in vitro. J Glaucoma 1996; 5:54-9.